Forced swim-induced musculoskeletal hyperalgesia is mediated by CRF2 receptors but not by TRPV1 receptors

Neuropharmacology

Volumn 72, Issue , 2013, Pages 29-37

  Abdelhamid, Ramy E ^a   Kovacs, Katalin J ^a   Pasley, Jeffrey D ^a   Nunez, Myra G ^a   Larson, Alice A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

CRF; Forced swim; Hyperalgesia; RTX; Stress; TRPV1; Urocortin

Indexed keywords

4 CHLORO N (3 METHOXYPHENYL)CINNAMAMIDE; ASTRESSIN; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; MORPHINE; NBI 35965; RESINIFERATOXIN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DOSE RESPONSE; DRUG MECHANISM; DRUG TREATMENT FAILURE; FEMALE; FORCED SWIMMING TEST; GRIP STRENGTH; HYPERALGESIA; MUSCULOSKELETAL PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STRESS;

EID: 84884880319     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.04.016     Document Type: Article

References (69)

1. Bishnoi, M., Bosgraaf, C.A., Abooj, M., Zhong, L., Premkumar, L.S., 2011a. Streptozotocin- induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediators. Mol. Pain 7, 52.
2. Bishnoi, M., Bosgraaf, C.A., Premkumar, L.S., 2011b. Preservation of acute pain and efferent functions following intrathecal resiniferatoxin-induced analgesia in rats. J. Pain 12, 991-1003.
3. Cavanaugh, D.J., Lee, H., Lo, L., Shields, S.D., Zylka, M.J., Basbaum, A.I., Anderson, D.J., 2009. Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuli. Proc. Natl. Acad. Sci. U. S. A. 106, 9075-9080.
4. Chung, M.K., Jung, S.J., Oh, S.B., 2011. Role of TRP channels in pain sensation. Adv. Exp. Med. Biol. 704, 615-636.
5. Churyukanov, M., Plaghki, L., Legrain, V., Mouraux, A., 2012. Thermal detection thresholds of Adelta- and C-fibre afferents activated by brief CO2 laser pulses applied onto the human hairy skin. PLoS One 7, e35817.
6. Coste, S.C., Murray, S.E., Stenzel-Poore, M.P., 2001. Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress. Peptides 22, 733-741. (Pubitemid 32397724)
7. Farkas-Szallasi, T., Bennett, G.J., Blumberg, P.M., Hokfelt, T., Lundberg, J.M., Szallasi, A., 1996. Vanilloid receptor loss is independent of the messenger plasticity that follows systemic resiniferatoxin administration. Brain Res. 719, 213-218. (Pubitemid 26173391)
8. Fekete, E.M., Zorrilla, E.P., 2007. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front. Neuroendocrinol. 28, 1-27. (Pubitemid 46533855)
9. Fernandes, E.S., Russell, F.A., Spina, D., McDougall, J.J., Graepel, R., Gentry, C., Staniland, A.A., Mountford, D.M., Keeble, J.E., Malcangio, M., Bevan, S., Brain, S.D., 2011. A distinct role for transient receptor potential ankyrin 1, in addition to transient receptor potential vanilloid 1, in tumor necrosis factor alpha-induced inflammatory hyperalgesia and Freund's complete adjuvantinduced monarthritis. Arthritis Rheum. 63, 819-829.
10. Fujii, Y., Ozaki, N., Taguchi, T., Mizumura, K., Furukawa, K., Sugiura, Y., 2008. TRP channels and ASICs mediate mechanical hyperalgesia in models of inflammatory muscle pain and delayed onset muscle soreness. Pain 140, 292-304.
11. Gibson, H.E., Edwards, J.G., Page, R.S., Van Hook, M.J., Kauer, J.A., 2008. TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron 57, 746-759. (Pubitemid 351335342)
12. Goso, C., Piovacari, G., Szallasi, A., 1993. Resiniferatoxin-induced loss of vanilloid receptors is reversible in the urinary bladder but not in the spinal cord of the rat. Neurosci. Lett. 162, 197-200. (Pubitemid 23347980)
13. Grisel, J.E., Fleshner, M., Watkins, L.R., Maier, S.F., 1993. Opioid and nonopioid interactions in two forms of stress-induced analgesia. Pharmacol. Biochem. Behav. 45, 161-172.
14. Hata, T., Kita, T., Itoh, E., Kawabata, A., 1988. The relationship of hyperalgesia in SART (repeated cold)-stressed animals to the autonomic nervous system. J. Auton. Pharmacol. 8, 45-52.
15. Hoheisel, U., Reinohl, J., Unger, T., Mense, S., 2004. Acidic pH and capsaicin activate mechanosensitive group IV muscle receptors in the rat. Pain 110, 149-157. (Pubitemid 38953278)
16. Holzer, P., 1988. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24, 739-768.
17. Hylden, J.L., Wilcox, G.L., 1980. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67, 313-316. (Pubitemid 10007057)
18. Iadarola, M.J., Mannes, A.J., 2011. The vanilloid agonist resiniferatoxin for interventional-based pain control. Curr. Top. Med. Chem. 11, 2171-2179.
19. Imbe, H., Iwai-Liao, Y., Senba, E., 2006. Stress-induced hyperalgesia: animal models and putative mechanisms. Front. Biosci. 11, 2179-2192. (Pubitemid 43822550)
20. Imbe, H., Okamoto, K., Donishi, T., Senba, E., Kimura, A., 2010. Involvement of descending facilitation from the rostral ventromedial medulla in the enhancement of formalin-evoked nocifensive behavior following repeated forced swim stress. Brain Res. 1329, 103-112.
21. Jorum, E., 1988. Noradrenergic mechanisms in mediation of stress-induced hyperalgesia in rats. Pain 32, 349-355.
22. Kanai, Y., Hara, T., Imai, A., Sakakibara, A., 2007. Differential involvement of TRPV1 receptors at the central and peripheral nerves in CFA-induced mechanical and thermal hyperalgesia. J. Pharm. Pharmacol. 59, 733-738. (Pubitemid 47051117)
23. Kehl, L.J., Hamamoto, D.T., Wacnik, P.W., Croft, D.L., Norsted, B.D., Wilcox, G.L., Simone, D.A., 2003. A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain. Pain 103, 175-186. (Pubitemid 36579097)
24. Kehl, L.J., Trempe, T.M., Hargreaves, K.M., 2000. A new animal model for assessing mechanisms and management of muscle hyperalgesia. Pain 85, 333-343. (Pubitemid 30214161)
25. Kim, Y.H., Back, S.K., Davies, A.J., Jeong, H., Jo, H.J., Chung, G., Na, H.S., Bae, Y.C., Kim, S.J., Kim, J.S., Jung, S.J., Oh, S.B., 2012. TRPV1 in GABAergic interneurons mediates neuropathic mechanical allodynia and disinhibition of the nociceptive circuitry in the spinal cord. Neuron 74, 640-647.
26. Kissin, I., Szallasi, A., 2011. Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials. Curr. Top. Med. Chem. 11, 2159-2170.
27. Kita, T., Hata, T., Iida, J., Yoneda, R., Isida, S., 1979. Decrease in pain threshold in SART stressed mice. Jpn. J. Pharmacol. 29, 479-482. (Pubitemid 9208770)
28. Korosi, A., Kozicz, T., Richter, J., Veening, J.G., Olivier, B., Roubos, E.W., 2007. Corticotropin- releasing factor, urocortin 1, and their receptors in the mouse spinal cord. J. Comp. Neurol. 502, 973-989. (Pubitemid 46806630)
29. Kovacs, K.J., Papic, J.C., Larson, A.A., 2008. Movement-evoked hyperalgesia induced by lipopolysaccharides is not suppressed by glucocorticoids. Pain 136, 75-84. (Pubitemid 351492590)
30. Lariviere, W.R., Melzack, R., 2000. The role of corticotropin-releasing factor in pain and analgesia. Pain 84, 1-12.
31. Light, A.R., Hughen, R.W., Zhang, J., Rainier, J., Liu, Z., Lee, J., 2008. Dorsal root ganglion neurons innervating skeletal muscle respond to physiological combinations of protons, ATP, and lactate mediated by ASIC, P2X, and TRPV1. J. Neurophysiol. 100, 1184-1201.
32. Lovick, T.A., 2008. Pro-nociceptive action of cholecystokinin in the periaqueductal grey: a role in neuropathic and anxiety-induced hyperalgesic states. Neurosci. Biobehav. Rev. 32, 852-862.
33. Marek, P., Mogil, J.S., Belknap, J.K., Sadowski, B., Liebeskind, J.C., 1993. Levorphanol and swim stress-induced analgesia in selectively bred mice: evidence for genetic commonalities. Brain Res. 608, 353-357. (Pubitemid 23111957)
34. Martinez, V., Wang, L., Rivier, J., Grigoriadis, D., Tache, Y., 2004. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice. J. Physiol. 556, 221-234. (Pubitemid 38515180)
35. Menigoz, A., Boudes, M., 2011. The expression pattern of TRPV1 in brain. J. Neurosci. 31, 13025-13027.
36. Mense, S., 1992. Peripheral mechanism of muscle nociception and local muscle pain. J. Musculoskelet. Pain 1, 133-170. (Pubitemid 23067859)
37. Mogil, J.S., Sternberg, W.F., Balian, H., Liebeskind, J.C., Sadowski, B., 1996. Opioid and nonopioid swim stress-induced analgesia: a parametric analysis in mice. Physiol. Behav. 59, 123-132. (Pubitemid 26008217)
38. O'Connor, P.J., Cook, D.B., 1999. Exercise and pain: the neurobiology, measurement, and laboratory study of pain in relation to exercise in humans. Exerc. Sport Sci. Rev. 27, 119-166.
39. Okamoto, K., Tashiro, A., Chang, Z., Thompson, R., Bereiter, D.A., 2012. Temporomandibular joint-evoked responses by spinomedullary neurons and masseter muscle are enhanced after repeated psychophysical stress. Eur. J. Neurosci. 36, 2025-2034.
40. Porsolt, R.D., 1979. Animal model of depression. Biomedicine 30, 139-140. (Pubitemid 9235293)
41. Porsolt, R.D., Bertin, A., Blavet, N., Deniel, M., Jalfre, M., 1979. Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur. J. Pharmacol. 57, 201-210. (Pubitemid 9250881)
42. Porsolt, R.D., Bertin, A., Jalfre, M., 1977. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229, 327-336. (Pubitemid 8225714)
43. Quintero, L., Cardenas, R., Suarez-Roca, H., 2011. Stress-induced hyperalgesia is associated with a reduced and delayed GABA inhibitory control that enhances post-synaptic NMDA receptor activation in the spinal cord. Pain 152, 1909-1922.
44. Quintero, L., Cuesta, M.C., Silva, J.A., Arcaya, J.L., Pinerua-Suhaibar, L., Maixner, W., Suarez-Roca, H., 2003. Repeated swim stress increases pain-induced expression of c-Fos in the rat lumbar cord. Brain Res. 965, 259-268. (Pubitemid 36183709)
45. Quintero, L., Moreno, M., Avila, C., Arcaya, J., Maixner, W., Suarez-Roca, H., 2000. Long-lasting delayed hyperalgesia after subchronic swim stress. Pharmacol. Biochem. Behav. 67, 449-458. (Pubitemid 32103551)
46. Reul, J.M., Holsboer, F., 2002. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2, 23-33.
47. Robbins, M.T., Ness, T.J., 2008. Footshock-induced urinary bladder hypersensitivity: role of spinal corticotropin-releasing factor receptors. J. Pain 9, 991-998.
48. Roberts, J.C., Davis, J.B., Benham, C.D., 2004. [3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution. Brain Res. 995, 176-183. (Pubitemid 37522018)
49. Roberts, K., Shenoy, R., Anand, P., 2011. A novel human volunteer pain model using contact heat evoked potentials (CHEP) following topical skin application of transient receptor potential agonists capsaicin, menthol and cinnamaldehyde. J. Clin. Neurosci. 18, 926-932.
50. Satoh, M., Kuraishi, Y., Kawamura, M., 1992. Effects of intrathecal antibodies to substance P, calcitonin gene-related peptide and galanin on repeated cold stress-induced hyperalgesia: comparison with carrageenan-induced hyperalgesia. Pain 49, 273-278.
51. Suarez-Roca, H., Leal, L., Silva, J.A., Pinerua-Shuhaibar, L., Quintero, L., 2008. Reduced GABA neurotransmission underlies hyperalgesia induced by repeated forced swimming stress. Behav. Brain Res. 189, 159-169.
52. Suarez-Roca, H., Quintero, L., Arcaya, J.L., Maixner, W., Rao, S.G., 2006a. Stressinduced muscle and cutaneous hyperalgesia: differential effect of milnacipran. Physiol. Behav. 88, 82-87. (Pubitemid 43795971)
53. Suarez-Roca, H., Silva, J.A., Arcaya, J.L., Quintero, L., Maixner, W., Pinerua- Shuhaibar, L., 2006b. Role of mu-opioid and NMDA receptors in the development and maintenance of repeated swim stress-induced thermal hyperalgesia. Behav. Brain Res. 167, 205-211. (Pubitemid 43099780)
54. Suaudeau, C., Costentin, J., 2000. Long lasting increase in nociceptive threshold induced in mice by forced swimming: involvement of an endorphinergic mechanism. Stress 3, 221-227. (Pubitemid 30423180)
55. Szabo, A., Helyes, Z., Sandor, K., Bite, A., Pinter, E., Nemeth, J., Banvolgyi, A., Bolcskei, K., Elekes, K., Szolcsanyi, J., 2005. Role of transient receptor potential vanilloid 1 receptors in adjuvant-induced chronic arthritis: in vivo study using gene-deficient mice. J. Pharmacol. Exp. Ther. 314, 111-119. (Pubitemid 41058247)
56. Szallasi, A., Blumberg, P.M., 1992. Vanilloid receptor loss in rat sensory ganglia associated with long term desensitization to resiniferatoxin. Neurosci. Lett. 140, 51-54.
57. Szallasi, A., Cortright, D.N., Blum, C.A., Eid, S.R., 2007. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat. Rev. Drug Discov. 6, 357-372. (Pubitemid 46705200)
58. Szallasi, A., Joo, F., Blumberg, P.M., 1989. Duration of desensitization and ultrastructural changes in dorsal root ganglia in rats treated with resiniferatoxin, an ultrapotent capsaicin analog. Brain Res. 503, 68-72. (Pubitemid 19279337)
59. Szallasi, A., Nilsson, S., Farkas-Szallasi, T., Blumberg, P.M., Hokfelt, T., Lundberg, J.M., 1995. Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res. 703, 175-183.
60. Telegdy, G., Adamik, A., Toth, G., 2006. The action of urocortins on body temperature in rats. Peptides 27, 2289-2294. (Pubitemid 44189623)
61. Tender, G.C., Li, Y.Y., Cui, J.G., 2008. Vanilloid receptor 1-positive neurons mediate thermal hyperalgesia and tactile allodynia. Spine J. 8, 351-358. (Pubitemid 351726322)
62. Turek, V.F., Ryabinin, A.E., 2005. Ethanol versus lipopolysaccharide- induced hypothermia: involvement of urocortin. Neuroscience 133, 1021-1028. (Pubitemid 40814609)
63. Vaccarino, A.L., Clavier, M.C., 1997. Blockade of tolerance to stress-induced analgesia by MK-801 in mice. Pharmacol. Biochem. Behav. 56, 435-439. (Pubitemid 27145823)
64. Varga, A., Nemeth, J., Szabo, A., McDougall, J.J., Zhang, C., Elekes, K., Pinter, E., Szolcsanyi, J., Helyes, Z., 2005. Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat. Neurosci. Lett. 385, 137-142. (Pubitemid 40961650)
65. Vidal, C., Jacob, J., 1986. Hyperalgesia induced by emotional stress in the rat: an experimental animal model of human anxiogenic hyperalgesia. Ann. N. Y. Acad. Sci. 467, 73-81. (Pubitemid 16029616)
66. Watabiki, T., Kiso, T., Kuramochi, T., Yonezawa, K., Tsuji, N., Kohara, A., Kakimoto, S., Aoki, T., Matsuoka, N., 2011a. Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect. J. Pharmacol. Exp. Ther. 336, 743-750.
67. Watabiki, T., Kiso, T., Tsukamoto, M., Aoki, T., Matsuoka, N., 2011b. Intrathecal administration of AS1928370, a transient receptor potential vanilloid 1 antagonist, attenuates mechanical allodynia in a mouse model of neuropathic pain. Biol. Pharm. Bull. 34, 1105-1108.
68. Wijnhoven, H.A., de Vet, H.C., Picavet, H.S., 2006. Prevalence of musculoskeletal disorders is systematically higher in women than in men. Clin. J. Pain 22, 717-724. (Pubitemid 44434955)
69. Zhou, H.Y., Chen, S.R., Chen, H., Pan, H.L., 2009. The glutamatergic nature of TRPV1- expressing neurons in the spinal dorsal horn. J. Neurochem. 108, 305-318.